Pharmacy-based preventive services for opioid use disorder: a survey of U.S. pharmacists
12/2024
Journal Article
Authors:
Wu, L. T.;
King, J.;
Hefner, K.;
Schactman, M.;
John, W.;
Hagemeier, N.;
Matthews, A. G.;
Levitt, N.;
Mannelli, P.
Volume:
19
Pagination:
88
Issue:
1
Journal:
Addict Sci Clin Pract
PMID:
39617932
URL:
https://www.ncbi.nlm.nih.gov/pubmed/39617932
DOI:
10.1186/s13722-024-00519-w
Keywords:
Humans *Opioid-Related Disorders/epidemiology/prevention & control Male Female *Pharmacists United States Adult *Community Pharmacy Services/organization & administration Middle Aged Surveys and Questionnaires Attitude of Health Personnel
Professional Role Buprenorphine Methadone Opioid use disorder
Abstract:
BACKGROUND: Pharmacists play a key role in combating the opioid-related overdose epidemic in the United States (US), but little is known about their experience and willingness to deliver preventive services for opioid use disorder (OUD). AIMS: This study seeks to identify correlates of pharmacists' concerns about drug use problems (prescription drug misuse/use disorder and illicit drug use/use disorder) as well as their practice experience delivering preventive services for OUD (e.g., asked about opioid use, provided advice, made a referral) and willingness to provide services to patients with drug use problems. DESIGN: An online survey of licensed US pharmacists was conducted. Participants were recruited from Community Pharmacy Enhanced Services Networks (CPESN) and state pharmacist associations (N = 1146). FINDINGS: Overall, 75% of surveyed pharmacists indicated having concerns about opioid use problems, and 62% had concerns about non-opioid drug use problems at their pharmacies. Pharmacists who were White, practiced at a rural location, worked at a chain pharmacy, had not received opioid-related training in the past year, or practiced screening patients for opioid use had elevated odds of perceiving concerns about opioid use problems in their practice settings. Pharmacists who were White, practiced at a rural location, or had not received opioid-related training in the past year had elevated odds of perceiving concerns about non-opioid (illicit) drug use problems. Being male, being White, or having received opioid-related training were associated with increased odds of screening patients for opioid use problems. Being White, having practiced at a rural location (vs. an urban location), being a pharmacy owner/manager, or having received opioid-related training were associated with increased odds of delivering opioid-related advice/intervention. Being male or having received opioid-related training were associated with increased odds of making a referral to OUD treatment. Finally, being male, being White, having practiced pharmacy services for under 6 years, having received opioid-related training for 2 h in the past year, or having performed OUD-related preventive services (asked about opioid use, provided advice, or made a referral) were associated with increased levels of commitment/readiness for providing care to patients with drug use problems. CONCLUSIONS: The overall findings highlight pharmacists' involvement with OUD preventive services. It is critical to promote opioid-related preventive service training for pharmacists and provide incentives/tools to help initiate a structured practice of delivering such preventive services.
